OncoTribune Contents

OncoTribune コンテンツ紹介


Congress Report



Executive Summary of Cancer Clinical Trials



Round Table Discussion


Latest Updates


ASCO-GI 2020 FLASH REPORT - Abstract 476 - 肝胆膵癌 Oral

Patient-reported outcomes (PROs) from the Phase III IMbrave150 trial of atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) as first-line treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC).
First Author: Peter R. Galle, MD, PhD

ASCO-GI 2020 FLASH REPORT - Abstract 5 - 大腸癌 Oral

Utility of circulating tumor DNA (ctDNA) versus tumor tissue clinical sequencing for enrolling patients (Pts) with advanced gastrointestinal (GI) cancer to matched clinical trials: SCRUM-Japan GI-SCREEN and GOZILA Combined Analysis.
First Author: Yoshiaki Nakamura

ASCO-GI 2020 FLASH REPORT - Abstract 281 - 食道癌 Oral

A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.
First Author: Maarten C.C.M. Hulshof, MD PhD

ASCO-GI 2020 FLASH REPORT - Abstract 100 - 大腸癌 Poster

VOLTAGE-B study: Nivolumab monotherapy and subsequent curative surgery following preoperative chemoradiotherapy in patients with locally recurrent rectal cancer (LRRC) without previous radiotherapy.
First Author: Takeshi Kato, MD, PhD

ASCO-GI 2020 FLASH REPORT - Abstract 478 - 肝胆膵癌 Oral

Nivolumab (NIVO) + ipilimumab (IPI) + cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
First Author: Thomas Yau

ASCO-GI 2020 FLASH REPORT - Abstract 7 - 大腸癌 Oral

A randomized phase III trial comparing primary tumor resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 study (iPACS).
First Author: Yukihide Kanemitsu, MD

ASCO-GI 2020 FLASH REPORT - Abstract 374 - 胃癌 Poster

An open-label phase II study of lenvatinib plus pembrolizumab in patients with advanced gastric cancer (EPOC1706).
First Author: Akihito Kawazoe

ASCO-GI 2020 FLASH REPORT - Abstract 383 - 胃癌 Poster

A phase III study of nivolumab (Nivo) in previously treated advanced gastric or gastric esophageal junction (G/GEJ) cancer (ATTRACTION-2): Three-year update data.
First Author: Li-Tzong Chen, MD, PhD

ASCO-GI 2020 FLASH REPORT - Abstract 178 - 大腸癌 Poster

Plasma VEGF-D and PlGF levels according to prior use of biologics among metastatic colorectal cancer: Preliminary results from GI-SCREEN CRC-Ukit study.


Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.

Kudo M, Finn RS, Qin S. et al. Lancet 2018; 391: 1163-73.